Molecular medicine 2 CYSTIC FIBROSIS and some other examples

1. Molecular medicine 2CYSTIC FIBROSIS and some other examples

2. Cystic fibrosis represents the first genetic disorder elucidated strictly by positional cloning Caused by mutations in the CFTR gene (cystic fibrosis transmembrane conductance regulator) which functions as a chloride channel and controls the regulation of other transport pathways • Most common severe autosomal recessive condition among Caucasians. • About 5% of white Caucasians of European descent are asymptomatic carriers. • Frequency of 1 / 2,500 affecting approximately 30,000 people

3. “Woe to that child which when kissed on the forehead tastes salty. He is bewitched and soon must die” Pathology Major symptoms due to dysfunction of exocrine glands sweat glands secrete excessive Na & Cl pancreatic ducts become blocked with thickened mucus → pancreatic insufficiency lungs produce a thickened mucus All of which give rise to: • Severe malabsorption • steatorrhoea • recurrent chest infections • sterility in males due to congenital bilateral aplasia of the vas deferens (CBAVD)

4. CF gene encodes a Cl- channel called CFTR(cystic fibrosis transmembrane conductance regulator) member of ATP binding cassette (ABC) membrane transporter superfamily 2 homologous halves -1480 amino acids long each half has 6 transmembrane domains (M1-12) & 1 nucleotide binding domain (NBD) which are linked by a cytoplasmic regulatory domain (R-domain) that contains phosphorylation sites

5. CFTR channel Minimum channel diameter – 5.3A Maximum channel diameter - 10-13A Charge selectivity: R352, cytoplasmic end of M6 Overall structure: Channel with a large extracellular vestibule which narrows towards the cytoplasmic end where the anion selectivity filter is located. Channel lining is formed by M1, M3, M6 & M12 segments. J Biol Chem (2000) vol 275 No 6 pp 3729 by MH Akabas

6. CFTR function • epithelial Cl- transport Cl- transport rate determined by activation of CFTR which in turn depends on its state of phosphorylation. • Acts as a regulator of other channels & transporters e.g CFTR mediates cAMP regulation of amiloride sensitive epithelial Na+ channels (EnaCs) http://www.infobiogen.fr/services/chromcancer/IntroItems/Images/CFTREnglFig2.jpg

7. Regulation of CFTR gating 2 processes control Cl- movement phosphorylation: necessary to activate the channel. The R domain contains phosphorylation sites for cAMP-dependent protein kinase A (PKA), C (PKC) and type II cGMP dependent protein kinases. CFTR deactivation mediated by phosphatases PP2C & PP2A. ATP binding & hydrolysis: Opening / closing of channel controlled by ATP binding & hydrolysis which occurs in the NBD segment. The R domain interacts with NBD & regulates their ATP affinity.

8. In 1985, CF locus was localized on the long arm of chromosome 7q31.2 In 1989, the gene implicated in CF was isolated (Kerem 1989; Riordan 1989; Rommens 1989).

9. CF from gene to product

10. CF gene encodes a cystic fibrosis transmembrane conductance regulator The genetic analysis showed that this gene, which is responsible for this disorder, contains 24 exons spreading over 250 kb of chromosome 7 (7q31) and encodes an mRNA of 6.5 kb.

11. Genotype- phenotype correlations

12. Spectrum of CF mutations that affect function

13. 70% of CF patients show a specific deletionF508 single amino acid (F) deletion in exon 10 encodes first portion of NBD-1 Leads to misfolding of CFTR in the endoplasmic reticulum (ER). Immature CFTR proteins are then polyubiquinated & targeted for proteosome degradation

14. Mapping of CFTR • 1985 gene for CF linked to enzyme paraoxanase (PON) • PON mapped to chromosome 7 and CF mapped to 7q31-32 (random DNA marker D7S15) • 2 flanking markers established (~2x106bp apart) • proximal MET oncogene and distal D7S8 • extensive mapping and characterisation around the candidate region by chromosome walking, chromosome jumping and microdissection (~300kbp cloned).

15. CFTR candidate region

16. Mapping of CFTR • 2 new markers identified – KM19 and XV2c – which showed strong linkage disequilibrium • 5’ end of gene located (undermethylated CpG islands was 1 tip-off) • Bovine equivalent of candidate gene isolated from genomic library • 7 cDNA libraries screened with human clone. 1 cDNA clone identified. Northern blots show 6.5 kb mRNA • Rest of the gene obtained by screening and PCR • 1989 CFTR gene eventually isolated by mutation screening

17. Letter to Dr. Collins. Courtesy of the National Human Genome Research Institute

18. Examples of diseases identified by • Direct identification by chromosome abnormality • Pure transcript mapping • Treacher collins Franschetti Syndrome • Large scale sequencing and homolog search

19. Pure transcript mapping Treacher Collins Franschetti Syndrome • Craniofacial development disorder • autosomal dominant disorder caused by mutations in ‘treacle’ gene TCOF1 • PATHOGENESIS • Wise et al. (1997) postulated that the disorder results from defects in a nucleolar trafficking protein that is critically required during human craniofacial development. Marsh et al. (1998) suggested that the disorder results from aberrant expression of a nucleolar protein. They observed that mutations in the TCOF1 gene (606847) cause truncated proteins to be mislocalized within the cell.